Many patients, especially those with a high pill burden and multiple chronic illnesses, are
less adherent to medication. In medication treatments utilizing polypills, this problem might …

In this guideline, the World Health Organization (WHO) provides the most current and
relevant evidence-based global public health guidance on the initiation of treatment with …

An adequate control of blood pressure is essential to reduce the risk of target organ
damages and cardiovascular events in patients with hypertension. Yet, it is well recognized …

Background The majority of people with hypertension require more than one medication to
achieve blood pressure control. Many patients are prescribed multipill antihypertensive …

Despite significant advances in health care over the last 50 years, the global cardiovascular
disease burden continues to increase with dire im‐plications. It is well known that …

Objective: The 2018 European Society of Cardiology/European Society of Hypertension
Guidelines for the management of arterial hypertension raised the need for evidence to …

Introduction: Current guidelines for pharmacotherapy briefly describe a role for combination
antihypertensive therapy. However, guidance on whether combination therapy should be …

Objectives The aim of the study was to compare therapy persistence among patients who
started with one of three drug regimens: a monotherapy, or combination therapy either as a …

Hypertension remains uncontrolled in approximately 50% of patients with hypertension,
which increases the risk of cardiovascular morbidity and mortality in these individuals. A key …

Aims We describe choice of first‐line antihypertensive drug therapy and uptake of fixed‐
dose combinations (FDCs) in Australia, and investigate the impact of initiation on FDCs and …